Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy
about
Cell biology of sarcomeric protein engineering: disease modeling and therapeutic potentialTargets for therapy in sarcomeric cardiomyopathiesResearch priorities in sarcomeric cardiomyopathiesClinical and Mechanistic Insights Into the Genetics of CardiomyopathyMybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in miceCorrection of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.Construction of microRNA and transcription factor regulatory network based on gene expression data in cardiomyopathyEED orchestration of heart maturation through interaction with HDACs is H3K27me3-independent.Increased Postnatal Cardiac Hyperplasia Precedes Cardiomyocyte Hypertrophy in a Model of Hypertrophic Cardiomyopathy.β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutationsSarcomere mutation-specific expression patterns in human hypertrophic cardiomyopathyGenetic advances in sarcomeric cardiomyopathies: state of the art.Reprogramming for cardiac regeneration.Developmental stage determines efficiency of gene transfer to muscle satellite cells by in utero delivery of adeno-associated virus vector serotype 2/9INHERIT (INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy-a Randomised Intervention Trial with losartan)Trbp regulates heart function through microRNA-mediated Sox6 repression.A roadmap to investigate the genetic basis of bicuspid aortic valve and its complications: insights from the International BAVCon (Bicuspid Aortic Valve Consortium).Cardiac myosin binding protein C regulates postnatal myocyte cytokinesis.MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutationAlterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte development.Decade in review--cardiomyopathies: Cardiomyopathy on the move.The genetic landscape of cardiomyopathy and its role in heart failure.Preventing pediatric cardiomyopathy: a 2015 outlook.Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.Cardiac gene therapy with adeno-associated virus-based vectors.Genome Editing for the Study of Cardiovascular Diseases.Genetics of paediatric cardiomyopathies.Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes.Preparation of rAAV9 to Overexpress or Knockdown Genes in Mouse Hearts.AAV9 Delivery of shRNA to the Mouse Heart.Genome-wide association study and biological pathway analysis of the Eimeria maxima response in broilers.ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy.Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival.Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.Hypothesis and theory: mechanical instabilities and non-uniformities in hereditary sarcomere myopathies.A map of human circular RNAs in clinically relevant tissues.Genome Editing: The Recent History and Perspective in Cardiovascular Diseases.Intrinsic MYH7 expression regulation contributes to tissue level allelic imbalance in hypertrophic cardiomyopathy.Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.Enlightening the Association between Bicuspid Aortic Valve and Aortopathy.
P2860
Q27010320-D6F84169-2AB0-44EE-8E80-9EEE872D9DF8Q27027023-A77ADDF2-25DE-4B62-B84A-27D3B1B7ECFFQ27694507-C08E69E9-0C43-4914-87C7-B189016FDA68Q28075470-5DAB422F-5A9B-4B4E-B254-8354C4D921D4Q28253008-39D84CFB-6B01-45C4-BD4E-F6813247C2DCQ30411331-94A8E188-8AB6-4399-918F-4A905155914EQ30863706-4CA1639B-0A55-4BF3-990B-E0B7E3E13A42Q33591193-0055B189-B01F-4062-AFFC-3E48D892BA12Q33795234-7A3C80FF-8F9D-4041-9066-0FC3BD8742BAQ33864019-C65F555E-1435-4A46-AA26-BE5C9BC19416Q34626001-F38149AB-79E0-4664-80A2-7930E426A55CQ35145962-27D6DA14-C7DC-485D-8981-04F7D344EDBDQ35156623-16629AEA-67A8-4730-8842-B5D214189784Q35184217-4D85A130-4BED-4A03-95FF-7DA250838226Q35217983-6A281073-1B58-4323-85F9-DF4197E7F102Q35798130-36BBA3B7-A3A0-41C7-A760-876435F8FFA7Q35798392-2FB84471-7ADD-46AD-B126-EDCDCA21C6A0Q35895661-186EAADC-D649-446C-8FC9-4FCF3087DB4DQ37625105-050921C7-1364-4D04-8745-95D543F86AF1Q37646848-79581EA4-58AA-4F29-9593-EEAC2A613FAFQ38255416-F763C4A1-34EA-4BBC-9E30-BE5F9485ABACQ38343935-DF23CCCC-C849-485C-BB17-929AA31178FBQ38662111-CB1C0AFE-E326-459E-879C-405893082C6EQ39050554-8777DB35-6C47-4371-94EA-A7D04D4EB380Q39124456-D364F104-B810-4391-A6C9-129C33A9E102Q39144904-8E559A0A-E60E-4D1F-BAC9-20BA2D6BF718Q39430716-3A232EC0-0171-4239-BB14-FF0890E82900Q40156224-A0377B27-624B-46B2-BF1C-1394C24E111CQ40392730-BCBCFD5C-FDAB-424A-9909-D6F55A92F1D7Q40671931-1AEE94A7-4361-44CA-B857-D26E4B0FA485Q40894981-61859116-7D9D-4B4F-A889-0894DBF19FB1Q41385002-613C64FA-7A03-4B35-A24E-10878E7B4955Q42159137-F9C69A0E-2AAE-4E47-8B0E-2815B4DB2BEFQ42515078-AC57318F-FE72-49E2-8791-E3F19082B80DQ42877248-428B015B-174D-4FCA-B75E-08A86FACADF3Q43061380-615790C9-B487-46CD-BB46-0AA1B19712D5Q45875285-F36E1485-DFDA-4950-8BA2-C95C4F75613CQ47157984-C6DB6A28-F7B1-4AE1-83CD-792BFB05F069Q47778748-70980A26-D5DC-4E42-8196-7B2B70A92722Q52718355-55D8D84F-F3C2-4358-96B8-055B99763689
P2860
Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Allele-specific silencing of m ...... es hypertrophic cardiomyopathy
@ast
Allele-specific silencing of m ...... es hypertrophic cardiomyopathy
@en
Allele-specific silencing of m ...... es hypertrophic cardiomyopathy
@nl
type
label
Allele-specific silencing of m ...... es hypertrophic cardiomyopathy
@ast
Allele-specific silencing of m ...... es hypertrophic cardiomyopathy
@en
Allele-specific silencing of m ...... es hypertrophic cardiomyopathy
@nl
prefLabel
Allele-specific silencing of m ...... es hypertrophic cardiomyopathy
@ast
Allele-specific silencing of m ...... es hypertrophic cardiomyopathy
@en
Allele-specific silencing of m ...... es hypertrophic cardiomyopathy
@nl
P2093
P2860
P356
P1433
P1476
Allele-specific silencing of m ...... es hypertrophic cardiomyopathy
@en
P2093
Christine E Seidman
Hiroko Wakimoto
J G Seidman
P2860
P356
10.1126/SCIENCE.1236921
P407
P577
2013-10-04T00:00:00Z